Derek Hicks
Corporate Officer/Principal bei INTELLIA THERAPEUTICS, INC.
Vermögen: 2 Mio $ am 31.03.2024
Profil
Derek Hicks is currently the Chief Business Officer & Executive Vice President at Intellia Therapeutics, Inc. Prior to this, he worked as the Head of Business Development at Spark Therapeutics, Inc. from 2020 to 2021.
Hicks has an undergraduate and graduate degree from the University of Connecticut and an MBA from the Kelley School of Business.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.03.2024 | 66 380 ( 0,07% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Derek Hicks
| Unternehmen | Position | Beginn |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Corporate Officer/Principal | 20.12.2021 |
Ehemalige bekannte Positionen von Derek Hicks
| Unternehmen | Position | Ende |
|---|---|---|
| SPARK THERAPEUTICS, INC. | Corporate Officer/Principal | 01.12.2021 |
Ausbildung von Derek Hicks
| University of Connecticut | Graduate Degree |
| Kelley School of Business | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. High, Jeffrey D. Marrazzo, J. Fraser Wright, and Jennifer Wellman on March 13, 2013 and is headquartered in Philadelphia, PA. | Health Technology |
